- Home
- OPFI vs STXS Comparison
OPFI vs STXS Comparison
Compare OPFI & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPFI
- STXS
- Stock Information
- Founded
- OPFI 2009
- STXS 1990
- Country
- OPFI United States
- STXS United States
- Employees
- OPFI N/A
- STXS N/A
- Industry
- OPFI Finance: Consumer Services
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- OPFI Finance
- STXS Health Care
- Exchange
- OPFI Nasdaq
- STXS Nasdaq
- Market Cap
- OPFI 288.7M
- STXS 244.1M
- IPO Year
- OPFI N/A
- STXS 2004
- Fundamental
- Price
- OPFI $9.61
- STXS $2.47
- Analyst Decision
- OPFI Buy
- STXS Strong Buy
- Analyst Count
- OPFI 2
- STXS 1
- Target Price
- OPFI $11.75
- STXS $4.00
- AVG Volume (30 Days)
- OPFI 769.2K
- STXS 699.5K
- Earning Date
- OPFI 10-29-2025
- STXS 11-11-2025
- Dividend Yield
- OPFI 2.60%
- STXS N/A
- EPS Growth
- OPFI N/A
- STXS N/A
- EPS
- OPFI 0.14
- STXS N/A
- Revenue
- OPFI $335,423,000.00
- STXS $30,075,000.00
- Revenue This Year
- OPFI $119.75
- STXS $30.98
- Revenue Next Year
- OPFI $10.98
- STXS $49.86
- P/E Ratio
- OPFI $70.05
- STXS N/A
- Revenue Growth
- OPFI 28.69
- STXS 19.62
- 52 Week Low
- OPFI $6.65
- STXS $1.54
- 52 Week High
- OPFI $17.73
- STXS $3.59
- Technical
- Relative Strength Index (RSI)
- OPFI 47.85
- STXS 45.41
- Support Level
- OPFI $9.04
- STXS $2.20
- Resistance Level
- OPFI $9.76
- STXS $2.38
- Average True Range (ATR)
- OPFI 0.42
- STXS 0.16
- MACD
- OPFI -0.00
- STXS -0.00
- Stochastic Oscillator
- OPFI 46.28
- STXS 49.37
About OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.